Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. (2020)
Attributed to:
COVID-19: multi-arm, multi stage adaptive clinical trial (CoV-MAMS)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s11684-020-0800-y
PubMed Identifier: 32621202
Publication URI: http://europepmc.org/abstract/MED/32621202
Type: Journal Article/Review
Volume: 14
Parent Publication: Frontiers of medicine
Issue: 5
ISSN: 2095-0217